Canadian Life Sciences NewsUncategorized

Canada Achieves New Psychedelic Milestone After Holding First Psilocybin Therapy Group Session

Canada Achieves New Psychedelic Milestone After Holding First Psilocybin Therapy Group Session

Canada held its first legal psilocybin therapy group session recently. Psilocybin is an active hallucinogenic compound found in magic mushrooms. Various studies conducted by major research institutions have found that psilocybin possesses therapeutic benefits. For instance, studies by Johns Hopkins University, New York University and the University of California Los Angeles have discovered that psilocybin can be used to effectively decrease end-of-life distress in patients with terminal conditions.

The session, which was hosted in Vancouver, British Columbia, was facilitated by My Community Journeys, a not-for-profit health-care organization. The therapy session included…

Read more »

NOTE TO INVESTORS: The latest news and updates relating to Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) are available in the company’s newsroom at

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published:

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
415.949.5050 Office

PsychedelicNewsWire is part of the InvestorBrandNetwork.

Related Articles

Back to top button